866-997-4948(US-Canada Toll Free)

Global Non-Insulin Therapies for Diabetes Market Research Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Insulin

No. of Pages : 123 Pages

Notes:
Production, means the output of Non-Insulin Therapies for Diabetes
Revenue, means the sales value of Non-Insulin Therapies for Diabetes

This report studies Non-Insulin Therapies for Diabetes in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Non-Insulin Therapies for Diabetes in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Alpha-Glucosidase Inhibitors
Amylin Agonists
Biguanides
Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Glinides/Meglitinides
GLP-1 Analogs/GLP-1 Agonists
Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
Sulfonylureas
Thiazolidinediones
Others
Split by application, this report focuses on consumption, market share and growth rate of Non-Insulin Therapies for Diabetes in each application, can be divided into
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others

Table of Contents

Global Non-Insulin Therapies for Diabetes Market Research Report 2017
1 Non-Insulin Therapies for Diabetes Market Overview
1.1 Product Overview and Scope of Non-Insulin Therapies for Diabetes
1.2 Non-Insulin Therapies for Diabetes Segment by Type
1.2.1 Global Production Market Share of Non-Insulin Therapies for Diabetes by Type in 2015
1.2.2 Alpha-Glucosidase Inhibitors
1.2.3 Amylin Agonists
1.2.4 Biguanides
1.2.5 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
1.2.6 Glinides/Meglitinides
1.2.7 GLP-1 Analogs/GLP-1 Agonists
1.2.8 Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
1.2.9 Sulfonylureas
1.2.10 Thiazolidinediones
1.2.11 Others
1.3 Non-Insulin Therapies for Diabetes Segment by Application
1.3.1 Non-Insulin Therapies for Diabetes Consumption Market Share by Application in 2015
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Non-Insulin Therapies for Diabetes Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Non-Insulin Therapies for Diabetes (2012-2022)

2 Global Non-Insulin Therapies for Diabetes Market Competition by Manufacturers
2.1 Global Non-Insulin Therapies for Diabetes Production and Share by Manufacturers (2015 and 2016)
2.2 Global Non-Insulin Therapies for Diabetes Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Non-Insulin Therapies for Diabetes Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Non-Insulin Therapies for Diabetes Manufacturing Base Distribution, Sales Area and Product Type
2.5 Non-Insulin Therapies for Diabetes Market Competitive Situation and Trends
2.5.1 Non-Insulin Therapies for Diabetes Market Concentration Rate
2.5.2 Non-Insulin Therapies for Diabetes Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Non-Insulin Therapies for Diabetes Production, Revenue (Value) by Region (2012-2017)
3.1 Global Non-Insulin Therapies for Diabetes Production and Market Share by Region (2012-2017)
3.2 Global Non-Insulin Therapies for Diabetes Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Non-Insulin Therapies for Diabetes Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Non-Insulin Therapies for Diabetes Consumption by Regions (2012-2017)
4.2 North America Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.3 Europe Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.4 China Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.5 Japan Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.7 India Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)

5 Global Non-Insulin Therapies for Diabetes Production, Revenue (Value), Price Trend by Type
5.1 Global Non-Insulin Therapies for Diabetes Production and Market Share by Type (2012-2017)
5.2 Global Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)
5.3 Global Non-Insulin Therapies for Diabetes Price by Type (2012-2017)
5.4 Global Non-Insulin Therapies for Diabetes Production Growth by Type (2012-2017)

6 Global Non-Insulin Therapies for Diabetes Market Analysis by Application
6.1 Global Non-Insulin Therapies for Diabetes Consumption and Market Share by Application (2012-2017)
6.2 Global Non-Insulin Therapies for Diabetes Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Non-Insulin Therapies for Diabetes Manufacturers Profiles/Analysis
7.1 GSK
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.1.2.1 Alpha-Glucosidase Inhibitors
7.1.2.2 Amylin Agonists
7.1.3 GSK Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Eli Lilly
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.2.2.1 Alpha-Glucosidase Inhibitors
7.2.2.2 Amylin Agonists
7.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Sumitomo Dainippon Pharma
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.3.2.1 Alpha-Glucosidase Inhibitors
7.3.2.2 Amylin Agonists
7.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Intarcia Therapeutics
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.4.2.1 Alpha-Glucosidase Inhibitors
7.4.2.2 Amylin Agonists
7.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Servier
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.5.2.1 Alpha-Glucosidase Inhibitors
7.5.2.2 Amylin Agonists
7.5.3 Servier Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Jiangsu Hansoh Pharmaceutical
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.6.2.1 Alpha-Glucosidase Inhibitors
7.6.2.2 Amylin Agonists
7.6.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.7.2.1 Alpha-Glucosidase Inhibitors
7.7.2.2 Amylin Agonists
7.7.3 Novo Nordisk Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Emisphere
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.8.2.1 Alpha-Glucosidase Inhibitors
7.8.2.2 Amylin Agonists
7.8.3 Emisphere Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Uni-Bio Science Group
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.9.2.1 Alpha-Glucosidase Inhibitors
7.9.2.2 Amylin Agonists
7.9.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Takeda
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
7.10.2.1 Alpha-Glucosidase Inhibitors
7.10.2.2 Amylin Agonists
7.10.3 Takeda Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 3SBio
7.12 Merck
7.13 Dong-A Pharmaceutical
7.14 Luye Pharma Group
7.15 Eurofarma
7.16 Geropharm
7.17 Alkem Labs
7.18 SatRx
7.19 Pfizer
7.20 Jiangsu Hengrui Medicine

8 Non-Insulin Therapies for Diabetes Manufacturing Cost Analysis
8.1 Non-Insulin Therapies for Diabetes Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Non-Insulin Therapies for Diabetes Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Non-Insulin Therapies for Diabetes Market Forecast (2017-2022)
12.1 Global Non-Insulin Therapies for Diabetes Production, Revenue and Price Forecast (2017-2022)
12.1.1 Global Non-Insulin Therapies for Diabetes Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Non-Insulin Therapies for Diabetes Price and Trend Forecast (2017-2022)
12.2 Global Non-Insulin Therapies for Diabetes Production, Consumption , Import and Export Forecast by Regions (2017-2022)
12.2.1 North America Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Non-Insulin Therapies for Diabetes Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Non-Insulin Therapies for Diabetes Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *